| abstract |
Pharmaceutical composition comprising a cholesterol absorption inhibitor and an HMG-CoA reductase inhibitor, one or more antioxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose. The composition does not need to contain ascorbic acid in order to obtain desirable stability. Claim 1: Pharmaceutical composition comprising from 1% to 20% by weight of ezetimibe; from 1% to 80% by weight of simvastatin; and from 0.01% to 2% by weight of BHA. |